Effect of polyphenolic compounds on the renal Na+, K+-ATPase during the restoration of normotension after experimentally induced hypertension in rats

Experimental Physiology

Volumn 88, Issue 4, 2003, Pages 475-482

  Javorková, Veronika ^a   Pechánová, Olga ^a   Andriantsitohaina, Ramaroson ^b   Vrbjar, Norbert ^a  

^a INSTITUTE OF CHEMISTRY   (Slovakia)

^b UNIVERSITÉ DE STRASBOURG   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); N(G) NITROARGININE METHYL ESTER; POLYPHENOL DERIVATIVE; SODIUM ION;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BINDING AFFINITY; BINDING SITE; BLOOD PRESSURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME KINETICS; HYPERTENSION; MALE; NONHUMAN; WINE;

EID: 0037770153     PISSN: 09580670     EISSN: None     Source Type: Journal    
DOI: 10.1113/eph8802553     Document Type: Article

References (26)

1. Andriambeloson E, Stoclet JC & Andriantsitohaina R (1999). Mechanism of endothelial nitric oxide-dependent vasorelaxation induced by wine polyphenols in rat thoracic aorta. J Cardiovasc Pharmacol 33, 248-254.
2. Barton CH, Ni Z & Vaziri ND (2001). Effect of severe aortic banding above the renal arteries on nitric oxide synthase isotype expression. Kidney Int 59, 654-661.
3. Bernátová I, Pechánová O, Babál P, Kyselá S, Štvrtina S & Andriantsitohaina R (2002). Wine polyphenols improve cardiovascular remodeling and vascular function in NO-deficient hypertension. Am J Physiol Heart Circ Physiol 282, H942-948.
4. Bernátová I, Pechánová O & Simko F (1996 . Captopril prevents NO-deficient hypertension and left ventricular hypertrophy without affecting nitric oxide synthase activity in rats. Physiol Res 45, 311-316.
5. Bernátová I, Pechánová O & Simko F (1999 . Effects of captopril in L-NAME-induced hypertension on the rat myocardium, aorta, brain and kidney. Exp Physiol 84, 1095-1105.
6. Blaustein MP, Ashida T, Goldman WF, Wier WG & Hamlyn JM (1986). Sodium/calcium exchange in vascular smooth muscle: a link between sodium metabolism and hypertension. Ann N Y Acad Sci 448, 199-216.
7. Bredt DS & Snyder SH (1990). Isolation of nitric oxide synthetase, a calmodulin-requiring enzyme. Proc Natl Acad Sci U S A 87, 682-685.
8. Hermsmeyer K (1982). Electrogenic ion pumps and other determinants of membrane potential in vascular muscle. Physiologist 25, 454-465.
9. +-ATPase α-subunit gene expression in hypertension. Science 241, 221-223.
10. Hertog MGL, Feskens EJM, Hollman PCH, Katan MB & Kroumhout D (1993). Dietary antioxidant flavonoids and risk of coronary heart diseases: the Zutphen Elderly Study. Lancet 342, 1007-1011.
11. +-ATPase: III. Purification from the outer medulla of mammalian kidney after selective removal of membrane components by sodium dodecylsulphate. Biochim Biophys Acta 356, 36-52.
12. 2+ binding and energy transduction in Na,K-ATPase. Biochim Biophys Acta 1505, 57-74.
13. Keli SO, Hertog MGL, Feskens EJM & Kroumhout D (1996). Dietary flavonoids, antioxidant vitamins and incidence of stroke. The Zutphen Study. Arch Intern Med 156, 637-642.
14. Lowry OH, Rosebrough NJ, Farr AL & Randall RJ (1951). Protein measurement with the folin phenol reagent. J Biol Chem 193, 265-275.
15. Magyar CE, Wang J, Azuma KK & McDonough AA (1995). Reciprocal regulation of cardiac Na-K-ATPase and Na/Ca exchanger: hypertension, thyroid hormone, development. Am J Physiol 269, C675-682.
16. Middleton E, Kandaswami C & Theoharides TC (2000). The effects of plant flavonoids on mammalian cells: implication for inflammation, heart disease and cancer. Pharmacol Rev 52, 673-751.
17. Miyagi Y, Miwa K & Inoue H (1997). Inhibition of human low density lipoprotein oxidation by flavonoids in red wine and grape juice. Am J Cardiol 15, 1627-1631.
18. Pamnani MB, Chen X, Haddy FJ, Schooley JF & Mo Z (2000). Mechanism of antihypertensive effect of dietary potassium in experimental volume expanded hypertension in rats. Clin Exp Hypertens 22, 555-569.
19. +-ATPase inhibition with bufalin impairs pressure natriuresis in the rat. Hypertension 27, 668-671.
20. Pechánová O & Bernátová I (2000). L-NAME induced hypertension: possibilities of its prevention and regression. Physiol Res 49, 2P.
21. St Leger AS, Cochrane AL & Moore F (1979). Factors associated with cardiac mortality in developed countries with particular reference to the consumption of wine. Lancet 1, 1017-1020.
22. Stumm MM, D'Orazio D, Sumanovski LT, Martin PY, Reichen J & Sieber CC (2002). Endothelial, but not the inducible, nitric oxide synthase is detectable in normal and portal hypertensive rats. Liver 22, 441-450.
23. +-ATPase isoforms in myocardium. Isoform change in deoxycorticosterone acetate-salt hypertension. Circ Res 74, 669-678.
24. Taussky HH & Shorr EE (1953). A microcolorimetric method for the determination of inorganic phosphorus. J Biol Chem 202, 675-685.
25. 2-isoform expression in guinea pig hearts during transition from compensation to decompensation. Am J Physiol Heart Circ Physiol 279, H1972-1981.
26. Vrbjar N, javorková V & Pechánová O (2002). Changes of sodium and ATP affinities of renal Na,K-ATPase during and after nitric oxide-deficient hypertension. Physiol Res 51, 475-482.